DOCSLIB.ORG

Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD September 2015 CONTENTS General Toxicology 7 Metals 35 Management 17 Pesticides 37 Drugs 20 Chemical Warfare 39 Chemical Incidents & 30 Plants 40 Pollution Chemicals 31 Animals 40 CURRENT AWARENESS PAPERS OF THE MONTH A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose Curtis RM, Sivilotti MLA. Clin Toxicol 2015; online early: doi: 10.3109/15563650.2015.1077968: Context Risk prediction following acetaminophen (paracetamol, APAP) overdose is based on serum APAP, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels. One recently proposed risk stratification tool, the APAPxAT multiplication product, uses either AST or ALT, whichever is higher, yet their interrelation is not well known following APAP- induced hepatic injury. Objective To describe the kinetics of AST and ALT release into and disappearance from the circulation following APAP overdose. Materials and Methods An observational case series of adult patients with peak AST or ALT > 100 IU/L attributable Current Awareness in Clinical Toxicology is produced monthly for the American Academy of Clinical Toxicology by the Birmingham Unit of the UK National Poisons Information Service, with contributions from the Cardiff, Edinburgh, and Newcastle Units. The NPIS is commissioned by Public Health England 2 to APAP toxicity. Cases were identified by electronic search of hospital laboratory database and by discharge diagnosis corroborated by structured explicit medical record review. Results Of 68 cases identified (mean age (SD): 39 (18) years, 63% female, and 21% ethanol co- ingested), 28 (41%) developed hepatotoxicity (peak AST or ALT > 1000 IU/L), 28 (41%) coagulopathy (international normalized ratio or INR > 2), and 21 (31%) both. Three patients (4%) were transferred for liver transplantation and ultimately six (8.8%) died. Serum AST and ALT activity rose in a closely aligned 1:1 AST:ALT ratio, but fell at distinctly different rates: AST activity fell with a half-life (interquartile range [IQR]) of 15.1 (12.2, 19.4) hours, and ALT 39.6 (32.9, 47.6) hours. Using an aminotransferase falling to below 50% of peak as the basis for discontinuing acetylcysteine would have resulted in antidotal treatment being stopped 24 (IQR: 9.6, 40) hours earlier (and in no cases later) using AST rather than ALT. Only six patients had an AST:ALT ratio greater than 2:1 at the time of acetylcysteine administration; of these six, four died and one survivor developed coagulopathy. Discussion AST and ALT release into the circulation appears tightly linked and numerically similar, except in the sickest patients. Once the aminotransferases peak, AST returns to baseline more quickly. Conclusion Either AST or ALT can be used for early risk stratification tools when only one is known. Any criterion for N-AC discontinuation should be based on the decline of AST rather than ALT, with a potential benefit measured in days. Full text available from: http://www.tandfonline.com/doi/abs/10.3109/15563650.2015.1077968 Phencyclidine analog use in Sweden–intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project Bäckberg M, Beck O, Helander A. Clin Toxicol 2015; online early: doi: 10.3109/15563650.2015.1079325: Background 3-Methoxy-phencyclidine (3-MeO-PCP) and 4-methoxy-phencyclidine (4-MeO-PCP) are analogs of and drug substitutes for the dissociative substance PCP ("Angel dust"), a recreational drug that was most popular in the 1970s. In Sweden, use of methoxylated PCP analogs was noted starting in mid-2013, according to statistics from the Poisons Information Centre. The objective of this case series was to present clinical and bioanalytical data from analytically confirmed non-fatal intoxications associated with 3-MeO-PCP and/or 4-MeO-PCP within the STRIDA project. Study design Observational case series of consecutive patients with self-reported or suspected exposure to new psychoactive substances (NPS) and who require hospital care. Patients and methods. Blood and urine samples were collected from intoxicated patients presenting at emergency departments (ED) or intensive care units (ICU) all over Sweden. NPS analysis was performed by multicomponent liquid chromatographic–tandem mass spectrometric (LC–MS/MS) and LC–high-resolution MS (LC–HRMS) methods. Data on clinical features were collected during Poisons Information Centre consultations and retrieved from medical records. 3 Results The Poisons Information Centre registered its first call related to methoxylated PCP analogs in July 2013, while analytically confirmed cases first appeared in October 2013. From July 2013 to March 2015, 1243 cases of suspected NPS intoxication originating from ED or ICU were enrolled in the STRIDA project. During the 21-month period, 56 (4.5%) patients tested positive for 3-MeO-PCP and 11 (0.9%) for 4-MeO-PCP; 8 of these cases involved both substances. The 59 patients were aged 14–55 (median: 26) years and 51 (86%) were men. Co-exposure to other NPSs and/or classical drugs of abuse was common with only 7 cases (12%) indicated to be 3-MeO-PCP single-substance intoxications; prominent clinical signs seen in the latter cases were hypertension (systolic blood pressure = 140 mmHg; 7 cases), tachycardia (= 100/min; 5 cases), and altered mental status (4 cases) including confusion, disorientation, dissociation, and/or hallucinations. Mixed-drug users displayed not only the same clinical features, but also more sympathomimetic effects including agitation (38%) and dilated pupils (33%). Patients testing positive for 3-/4-MeO-PCP were typically under medical care for 1–2 days (85%), and 37% of all cases were graded as severe intoxications (Poisoning Severity Score 3). Besides standard supportive therapy, 49% of the patients were treated with benzodiazepines and/or propofol. Conclusion Laboratory analysis constitutes an important basis for the assessment of NPS hazard and availability. The adverse effects noted in cases of acute intoxications involving 3- and/or 4- MeO-PCP resembled those of other dissociatives such as PCP, ketamine, and methoxetamine. However, similar to intoxications involving other NPS, poly-substance use was found to be common. Full text available from: http://www.tandfonline.com/doi/abs/10.3109/15563650.2015.1079325 Disproportionate effect on child admissions of the change in MHRA guidance for management of paracetamol poisoning: an analysis of hospital admissions for paracetamol overdose in England and Scotland Narayan H, Thomas SH, Eddleston M, Dear JW, Sandilands E, Bateman DN. Br J Clin Pharmacol 2015; online early: doi: 10.1111/bcp.12779: Abstract and full text available from: http://dx.doi.org/10.1111/bcp.12779 Paracetamol overdose in Hong Kong: is the 150-treatment line good enough to cover patients with paracetamol-induced liver injury? Chan STB, Chan CK, Tse ML. Hong Kong Med J 2015; online early: doi: 10.12809/hkmj144481: Abstract and full text available from: http://dx.doi.org/10.12809/hkmj144481 Pharmacological treatment of organophosphorus insecticide poisoning: the old and the (possible) new Eddleston M, Chowdhury FR. Br J Clin Pharmacol 2015; online early: doi: 10.1111/bcp.12784: Abstract and full text available from: http://dx.doi.org/10.1111/bcp.12784 4 Long-acting anticoagulant rodenticide (superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management King N, Tran M-H. Transfus Med Rev 2015; online early: doi: 10.1016/j.tmrv.2015.06.002: Abstract and full text available from: http://dx.doi.org/10.1016/j.tmrv.2015.06.002 Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double- blind phase 1 trial Glund S, Stangier J, Schmohl M, Gansser D, Norris S, Van Ryn J, Lang B, Ramael S, Moschetti V, Gruenenfelder F, Reilly P, Kreuzer J. Lancet 2015; 386: 15-21. Abstract and full text available from: http://dx.doi.org/10.1016/S0140-6736(15)60732-2 Aminocaproic acid and tranexamic acid fail to reverse dabigatran-induced coagulopathy Levine M, Huang M, Henderson SO, Carmelli G, Thomas SH. Am J Ther 2015; online early: doi: 10.1097/MJT.0000000000000216: Abstract and full text available from: http://dx.doi.org/10.1097/MJT.0000000000000216 Calcium channel and beta-blocker antagonist antidotes and adjunct therapies Graudins A, Lee HM, Druda D. Br J Clin Pharmacol 2015; online early: doi: 10.1111/bcp.12763: Abstract and full text available from: http://dx.doi.org/10.1111/bcp.12763 Buprenorphine infrequently found in fatal overdose in New York City Paone D, Tuazon E, Stajic M, Sampson B, Allen B, Mantha S, Kunins H. Drug Alcohol Depend 2015; online early: doi: 10.1016/j.drugalcdep.2015.08.007: Abstract and full text available from: http://dx.doi.org/10.1016/j.drugalcdep.2015.08.007 Role of extracorporeal membrane oxygenation in aluminum phosphide poisoning-induced reversible myocardial dysfunction: a novel therapeutic modality Mohan B, Gupta V, Ralhan S, Gupta D, Puri S, Wander GS, Singh B. J Emerg Med 2015; online early: doi: 10.1016/j.jemermed.2015.06.071: Abstract and full text available from: http://dx.doi.org/10.1016/j.jemermed.2015.06.071 5 Acute toluene intoxication-clinical presentation, management and prognosis: a prospective observational study Camara-Lemarroy CR, Rodríguez-Gutiérrez R, Monreal-Robles R, González-González JG. BMC Emerg Med 2015; 15: 19. Abstract and full text available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539858/ Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure Scherneck S, Schöpa FL, Entezami M, Kayser A, Weber-Schoendorfer C, Schaefer C. Reprod Toxicol 2015; 58: 61-4. Abstract and full text available from: http://dx.doi.org/10.1016/j.reprotox.2015.08.002 Epidemiology of ciguatera in Florida Radke EG, Reich A, Morris JG, Jr.
Load more

Recommended publications
  • Cómo Citar El Artículo Número Completo Más Información Del
    Acta Pediátrica de México ISSN: 0186-2391 ISSN: 2395-8235 [email protected] Instituto Nacional de Pediatría México Avilés-Martínez, Karla Isis; Villalobos-Lizardi, José Carlos; López-Enríquez, Adriana Venta clandestina de rodenticidas, un problema de salud pública. Reporte de dos casos Acta Pediátrica de México, vol. 40, núm. 2, 2019, pp. 71-84 Instituto Nacional de Pediatría México Disponible en: https://www.redalyc.org/articulo.oa?id=423665708004 Cómo citar el artículo Número completo Sistema de Información Científica Redalyc Más información del artículo Red de Revistas Científicas de América Latina y el Caribe, España y Portugal Página de la revista en redalyc.org Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto CASO CLÍNICO DE INTERÉS ESPECIAL Acta Pediatr Mex. 2019 marzo-abril;40(2):71-84. Venta clandestina de rodenticidas, un problema de salud pública. Reporte de dos casos Clandestine sale of rodenticides, a health problem. Report of two cases Karla Isis Avilés-Martínez,1 José Carlos Villalobos-Lizardi,2 Adriana López-Enríquez3 Resumen ANTECEDENTES: La venta clandestina de rodenticidas es una manifestación de la pobreza y la exclusión social. Los rodenticidas adquiridos en estas circunstancias son accesibles porque tienen un canal de distribución eficiente. Su disponibilidad en casa, sin medidas de seguridad adecuadas y estrictas, representa un problema de salud potencialmente letal debido al contenido, falsificación, adulteración y etiquetado inadecuado o ausente. CASOS CLÍNICOS: Se reportan dos casos clínicos, no letales, de niños previamente sanos que ingirieron rodenticidas no etiquetados y obtenidos de la venta ilegal ambulante. El primer caso sufrió intoxicación por difetaliona (Clase Ia), rodenticida anticoagulante de segunda generación (en la bibliografía se reporta intoxicación en dos niños).
    [Show full text]
  • Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-Target Organisms Katherine Horak U.S
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln USDA National Wildlife Research Center - Staff U.S. Department of Agriculture: Animal and Plant Publications Health Inspection Service 2018 Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-target Organisms Katherine Horak U.S. Department of Agriculture, [email protected] Penny M. Fisher Landcare Research Brian M. Hopkins Landcare Research Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc Part of the Life Sciences Commons Horak, Katherine; Fisher, Penny M.; and Hopkins, Brian M., "Pharmacokinetics of Anticoagulant Rodenticides in Target and Non- target Organisms" (2018). USDA National Wildlife Research Center - Staff Publications. 2091. https://digitalcommons.unl.edu/icwdm_usdanwrc/2091 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA National Wildlife Research Center - Staff ubP lications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Chapter 4 Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-target Organisms Katherine E. Horak, Penny M. Fisher, and Brian Hopkins 1 Introduction The concentration of a compound at the site of action is a determinant of its toxicity. This principle is affected by a variety of factors including the chemical properties of the compound (pKa, lipophilicity, molecular size), receptor binding affinity, route of exposure, and physiological properties of the organism. Many compounds have to undergo chemical changes, biotransformation, into more toxic or less toxic forms. Because of all of these variables, predicting toxic effects and performing risk assess- ments of compounds based solely on dose are less accurate than those that include data on absorption, distribution, metabolism (biotransformation), and excretion of the compound.
    [Show full text]
  • Report on the Human Health Risk Assessment for the Lord Howe Island’S Proposed Rodent Eradication Program NSW Chief Scientist & Engineer
    Report on the Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program NSW Chief Scientist & Engineer July 2017 www.chiefscientist.nsw.gov.au/reports/independent-review-of-the-lord-howe-island-rodent- eradication-project The Hon. Gabrielle Upton MP Minister for the Environment Minister for Local Government Minister for Heritage 52 Martin Place SYDNEY NSW 2000 Dear Minister, Report – Independent Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program In June 2016, your predecessor wrote requesting that I assist the Lord Howe Island Board in undertaking an independent Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program in line with the Terms of Reference (see Appendix 1). As planned, an Expert Panel was convened and a suitable firm procured (Ramboll Environ Pty. Ltd.) to undertake the Human Health Risk Assessment, with input and review of the Expert Panel. The purpose of this report is to provide you with an overview of the process, the finding of the Human Health Risk Assessment and some observations and recommendations. The report of Ramboll’s is included as Appendix 2 of this report. I understand that the Human Health Risk Assessment is important for the Lord Howe Island community. During discussion between the Lord Howe Island Board (the Board) and my office, the Board has expressed an interest in representatives from the Expert Panel and the Office of the Chief Scientist & Engineer attending the island to participate in a community engagement event, discussing the outcomes of the Human health Risk Assessment.
    [Show full text]
  • Anticoagulant Rodenticide Intoxication in Animals - a Review
    Turk. J. Vet. Anim. Sci. 2008; 32(4): 237-243 © TÜB‹TAK Review Article Anticoagulant Rodenticide Intoxication in Animals - A Review Ivan VALCHEV, Rumen BINEV*, Veska YORDANOVA, Yordan NIKOLOV Department of Internal Medicine, Faculty of Veterinary Medicine, Trakia University, Stara Zagora - BULGARIA Received: 18.07.2006 Abstract: The newest measures for the control of harmful rodent populations are from the anticoagulant rodenticide group, which are divided into 2 subgroups: first and second generations, and indandione derivatives. Non-target organisms are potentially at risk of direct consumption of baits (primary hazard) and of eating poisoned rodents (secondary hazard). Anticoagulant rodenticides inhibit the enzyme vitamin K-dependent carboxylase and thus impair the reactivation of vitamin K1, indirectly affecting physiological blood coagulation. The diagnosis is made on the basis of clinical signs (massive hemorrhages), laboratory findings, and especially the changes in coagulation markers (APTT, PT, TT, PCT, ACT, FDPs, and PIVKA). The specific antidote is vitamin K1. The general prophylaxis consists of placing baits out of reach of animals, daily control of baits and dead rodents, which are to be timely removed. Key Words: Intoxication, anticoagulant rodenticides, animals Introduction O O O Anticoagulant rodenticides are the largest group of CO pesticides used for control of harmful rodents (1-4). For the same purpose, derivatives of bromethalin, O cholecalciferol, and sodium fluoroacetate are also used OH (5-7). However, their application is very limited while Hydroxycoumarin rodenticides Indandione rodenticides inorganic rodenticides (phosphorus- and arsenic- Figure 1. Chemical structure of anticoagulant rodenticides. containing) are not used. Hydroxycoumarin compounds were discovered in the 1940s and have been in continuous use since then (4,8,9).
    [Show full text]
  • Diretrizes Brasileiras Para Tratamento De Intoxicações Por Agrotóxicos
    Diretrizes Brasileiras para Diagnóstico e Tratamento de Intoxicações por Agrotóxicos - Capítulo 1 Nº 387 Agosto/2018 1 2018 Ministério da Saúde. É permitida a reprodução parcial ou total desta obra, desde que citada a fonte e que não seja para venda ou qualquer fim comercial. A responsabilidade pelos direitos autorais de textos e imagens desta obra é da CONITEC. Informações: MINISTÉRIO DA SAÚDE Secretaria de Ciência, Tecnologia e Insumos Estratégicos Esplanada dos Ministérios, Bloco G, Edifício Sede, 8° andar CEP: 70058-900, Brasília – DF E-mail: [email protected] http://conitec.gov.br 2 CONTEXTO Em 28 de abril de 2011, foi publicada a Lei n° 12.401, que altera diretamente a Lei nº 8.080 de 1990 dispondo sobre a assistência terapêutica e a incorporação de tecnologias em saúde no âmbito do SUS. Esta lei define que o Ministério da Saúde, assessorado pela Comissão Nacional de Incorporação de Tecnologias – CONITEC, tem como atribuição incorporar, excluir ou alterar o uso de tecnologias em saúde, tais como medicamentos, produtos e procedimentos, bem como a constituição ou alteração de Protocolos Clínicos e Diretrizes Terapêuticas. Os Protocolos Clínicos e DiretrizesTerapêuticas (PCDT) são os documentos oficiais do SUS para estabelecer os critérios para o diagnóstico de uma doença ou agravo à saúde; o tratamento preconizado, com os medicamentos e demais produtos apropriados, quando couber; as posologias recomendadas; os mecanismos de controle clínico; e o acompanhamento e a verificação dos resultados terapêuticos a serem seguidos pelos gestores do SUS. O objetivo de um PCDT é garantir o melhor cuidado de saúde possível diante do contexto brasileiro e dos recursos disponíveis no Sistema Único de Saúde, de forma a garantir sua sustentabilidade.
    [Show full text]
  • Basic Analytical Toxicology
    The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 190 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such coopera­ tion among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition, controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other preventable diseases; improving mental health; providing safe water supplies; and training health personnel of all categories. Progress towards better health throughout the world also demands international cooperation in such matters as establishing international standards for biological substances, pesticides and pharma­ ceuticals; formulating environmental health criteria; recommending international nonproprietary names for drugs; administering the International Health Regulations; revising the International Statistical Classification of Diseases and Related Health Problems and collecting and disseminating healih statistical information.
    [Show full text]
  • The Humaneness of Rodent Pest Control
    THE HUMANENESS OF RODENT PEST CONTROL G Mason* and K E Littin t * Animal Behaviour Research Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK Animal Welfare Science and Bioethics Centre, Massey University, New Zealand * Contact for correspondence and requests for reprints: [email protected] Abstract Animal Welfare 2003,12: 1-37 Rat and mouse control methods potentially affect the welfare of many millions of animals every year. Here, the humaneness of the methods used in the UK and the USA is assessed in terms of their speed and mode of action, the appearance and behaviour of affected animals, experiences of human victims, long-term effects on animals that survive exposure, and welfare risks to non-target animals. Several methods emerge as relatively humane: cyanide, alpha-chloralose, electrocution traps and well-designed snap traps all usually kill swiftly and with little distress. Preventative methods such as rodent-proofing are also humane, as well as an essential - and probably under-used - component of effective control. However, anticoagulant poisons, the most common means of controlling rodents, generally take several days to kill, during which time they cause distress, disability and/or pain. Sub-lethally affected animals are also likely to experience haemorrhages and their sequelae, and carnivores feeding on affected rodents may be secondarily poisoned. The acute rodenticides zinc phosphide and calciferol are also generally inhumane, the former typically causing severe pain for several hours, and the latter, pain and illness for several days. Sticky boards, to which rodents become adhered by thefeet and fur until they are killed or simply eventually die, also raise very serious welfare concerns.
    [Show full text]
  • Reducing Rodenticide Hazards to Humans and Wildlife: the Need for Use Regulations
    REDUCING RODENTICIDE HAZARDS TO HUMANS AND WILDLIFE: THE NEED FOR USE REGULATIONS MICHAEL FRY, Pesticides and Birds Program . American Bird Conservancy, Washington DC, USA Abstract: Rodenticide use poses significant exposure risks for children and poisoning risks for native wild birds and mammals in the United States. Poison Contro l Center reports document 15,000 calls annually identifying household rat poison ingestion , with 88% of cases for children under age six. Wildlife poisonings from ingestion of baits or treated grain may occur whenever birds or mammals have access to the products. This is especially true for broadcast baits and treated grain used above ground in agricultural settings, or when baits are distributed around structures or outside waste containers. Secondary poisoning of predators and scavengers occurs when target rodents are moribund or die above ground in locations accessible to predatory birds or mammals . Secondary poisoning risks appear to be highest for the "seco nd generation" anticoagulant rodenticides , becaus e rodents consume them in super-lethal doses in multiple feedings during the 4-6 days required for these poisons to kill the target rodents. These anticoagulants persist for long periods in tissues of scavengers and predators , increasing the risk of adverse effects from subsequent feedings on poisoned rodents. The risk of both human and wildlife poisonings can be greatly reduced by packaging rodenticides in bait stations and restricting the use of second generation product s to licensed pest control operators. Key words: anticoagulant rodenticides, brodifacoum , bromadiolone , chlorophacinone, diphacinone , rodent, seco ndary toxicity , strychnine, warfarin, zinc phosphide Proceeding s of the 12th Wildlife Dama ge Management Conference (D.L.
    [Show full text]
  • LONG-LASTING ANTI-COAGULANTS (Super Warfarin)
    LONG-LASTING ANTI-COAGULANTS (Super Warfarin) I. Protocol Overview Warfarin (Coumadin, or bis-hydroxycoumarin) is used therapeutically as anticoagulants and commercially as rodenticides. Several long-acting coumarin derivatives, or superwarfarins (brodifacoum, diphenadione, chlorophacinone, bromadiolone) are used as rodenticides and can produce profound and prolonged anticoagulation. Most patients are asymptomatic after an unintentional ingestion. Signs of decreased clotting ability (coagulopathy) typically occur within 24-72 hours post significant ingestion of a long-acting anticoagulant, and may present as nose and gum (epistaxis, gingival) bleeding, as well as bloody vomit, urine, feces, or uterus, (hematemesis, hematuria, hematochezia, menometrorrhagia), discoloration, splotching, and bleeding of the skin, tissues, and brain (ecchymosis, petechial hemorrhages, intracranial hemorrhages) or bleeding not in proportion with the injury. For all suspected chemical exposures, consult the Poison Control Center (800-222-1222) located at Children’s Hospital of Philadelphia. Information and treatment advice is available to the public and healthcare professionals at no charge. Long-lasting anticoagulants are detected indirectly through prolonged prothrombin time (PT) and international normalized ratio (INR) (24 to 72 hours after exposure) persisting for weeks to months, as determined by hospital laboratory tests or abnormal assays for factors II and VII in patients with unexplained bleeding and a normal PT, partial thromboplastin time, or INR, as determined by hospital or commercial laboratory tests. Serum levels of long lasting anticoagulant rodenticides can be determined using High-performance liquid chromatographic (HPLC) methods with ultraviolet (UV) and fluorescence detection. Liquid chromatography tandem mass spectrometry (LC/MS/MS) methods are used to detect long lasting anticoagulant rodenticides in food and environmental samples.
    [Show full text]
  • Rodenticides - Kramer R.E
    ENVIRONMENTAL TOXICOLOGY AND HUMAN HEALTH – Vol. I - Rodenticides - Kramer R.E. and Baker R.C. RODENTICIDES Kramer R.E. and Baker R.C. Department of Pharmacology and Toxicology, University of Mississippi Medical Center, U.S.A. Keywords: Fluoroacetate, sodium monofluoroacetate, compound 1080, fluorocitrate, fluoroacetamide, compound 1081, 1,3-difluoro-2-propanol, DFP, thiourea, α- naphthylthiourea, ANTU, pyriminil, PNU, Vacor, bromethalin, vitamin D, cholecalciferol, ergocalciferol, norbormide, scillirosides, scillirosidin, glycosides, α- chlorohydrin, thallium, phosphorus, zinc phosphide, aluminum phosphide, phosphine, strychnine, anticoagulants, brodifacoum, bromadiolone, chlorophacinone, coumachlor, difenacoum, diphencoumarin, difethialone, diphacinone, flocoumafen, pindone, warfarin, vitamin K, mechanisms of action, toxicity, treatment; antidotes Contents 1. Introduction 2. Fluoroacetate derivatives 2.1. Sodium Monofluoroacetate 2.2. Fluoroacetamide 2.3. 1,3-Difluoro-2-propanol 3. Thiourea Rodenticides 3.1. α-Naphthylthiourea (ANTU) 3.2. Pyriminil 4. Bromethalin 5. Vitamin D-based rodenticides 6. Norbormide 7. Scilliroside 8. Alpha (α)-chlorohydrin 9. Thallium 10. Yellow phosphorus 11. Zinc phosphide 12. Strychnine 13. Anticoagulant rodenticides Glossary BibliographyUNESCO – EOLSS Biographical Sketches SAMPLE CHAPTERS Summary A rodenticide is defined as any compound used to kill rodents or other small animals. They are widely used, and as a class encompass a disparate group of compounds with differing structures and mechanisms of action.
    [Show full text]
  • Simultaneous Bleeding and Thrombosis in Superwarfarin Poisoning
    Thrombosis Research (2009) 123, 637–639 www.elsevier.com/locate/thromres BRIEF COMMUNICATION Simultaneous bleeding and thrombosis in superwarfarin poisoning Erich Vinicius De Paula a,⁎, Silmara Aparecida Lima Montalvao a, Paulo Roberto Madureira b, Ronan Jose Vieira b, Joyce Maria Annichino-Bizzacchi b, Margareth Castro Ozelo a a Hematology and Hemotherapy Center, State University of Campinas, Brazil b School of Medical Sciences, State University of Campinas, Campinas, SP, Brazil Received 23 December 2007; received in revised form 29 January 2008; accepted 5 February 2008 Available online 18 April 2008 Superwarfarin poisoning causes a severe acquired Case report coagulation disorder that, despite its frequency, severity and specific therapeutic implications, still A 24-year-old male presented to the emergency goes largely unrecognized by physicians. Hematol- room with gross hematuria and a 20-day long history ogists are often called to evaluate these patients, of melena and gingival bleeding. The patient also but unawareness of the specificities of the problem presented pain and swelling in the left knee which, often precludes adequate diagnosis and treatment. given the initial laboratory results, was interpreted Superwarfarin poisoning differs from coumarin over- as a hemarthrosis. He had a history of heavy alco- dose in that the former is resistant to reversal with hol consumption and had been taking disulfiram standard doses of vitamin K, and that anticoagulant 250 mg/day for 6 months to support treatment of effects can last for weeks after drug discontinuation. chronic alcoholism. Laboratory workup revealed Here we report a case of superwarfarin poisoning with prolonged prothrombin time (PTN300 s) and acti- a previously unreported clinical presentation, in which vated partial thromboplastin time (APTT=88.1 s), diffuse bleeding and venous thrombosis were simulta- which were both corrected on mixing studies.
    [Show full text]
  • Superwarfarin Poisoning
    ORIGINAL INVESTIGATION Superwarfarin Poisoning Jimmy Dy Chua, MD; William R. Friedenberg, MD Background: Superwarfarin sodium exposure or poi- accidentally ingested superwarfarin or attempted sui- soning is a growing public health problem. There were 5133 cide using it were easily diagnosed, while diagnosis was reported cases of superwarfarin exposure and poisoning markedly delayed for the 2 patients with Munchausen in 1988 and 13 423 cases in 1995. Cases may be associ- syndrome. Full reversal of anticoagulation was quickly ated with accidental exposure, suicide attempts, or Mun- achieved in the cases of accidental ingestion and at- chausen syndrome, and may be difficult to diagnose. tempted suicide. We examined and treated the patients with Munchausen syndrome for months before estab- Patients and Methods: Patients from northern Wis- lishing a diagnosis and fully reversing the anticoagula- consin with superwarfarin exposure or poisoning were tion. None of the patients in our study died of superwar- examined at a tertiary referral center in rural Wisconsin farin poisoning. to determine what led to their exposure and to review the clinical manifestations, diagnosis, treatment, and pre- Conclusions: Superwarfarin exposure or poisoning is vention of superwarfarin poisoning. a growing public health problem that should be part of the differential diagnosis of patients who present with a Results: Eleven cases satisfied the criteria for superwar- coagulopathy consistent with vitamin K deficiency in the farin exposure or poisoning. All 7 children included in absence of coumadin therapy, liver disease, or the use of the study had accidentally ingested superwarfarin, 2 adults an inhibitor, and whose conditions do not resolve with had Munchausen syndrome, and 1 teenager and 1 adult large doses of parenteral vitamin K1 therapy.
    [Show full text]